ImportRefusal LogoImportRefusal

Janssen Pharmaceutical

⚠️ Moderate Risk

FEI: 3007501739 • Kiton Shanzi • CHINA

FEI

FEI Number

3007501739

📍

Location

Kiton Shanzi

🇨🇳

Country

CHINA
🏢

Address

Wan Shau N. Rd. 34, , Kiton Shanzi, , China

Moderate Risk

FDA Import Risk Assessment

35.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
5
Unique Violations
4/1/2013
Latest Refusal
3/7/2013
Earliest Refusal

Score Breakdown

Violation Severity
58.2×40%
Refusal Volume
25.9×30%
Recency
0.0×20%
Frequency
40.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

164×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

37414×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(o) in that it is being imported or offered for import into the United States, and the importer, owner, or consignee of such article did not, at the time of offering the article for import, submit to the Secretary a statement that identifies the registration under section 510(i) of the Act of each establishment that with respect to such article is required under such section to register with the Secretary.

754×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

Refusal History

DateProductViolationsDivision
4/1/2013
66VDE99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3741FRNMFGREG
75UNAPPROVED
Division of Northeast Imports (DNEI)
4/1/2013
66VDE99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3741FRNMFGREG
75UNAPPROVED
Division of Northeast Imports (DNEI)
4/1/2013
66VDE99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3741FRNMFGREG
75UNAPPROVED
Division of Northeast Imports (DNEI)
3/7/2013
61TCA31DOMPERIDONE
118NOT LISTED
16DIRECTIONS
3741FRNMFGREG
472NO ENGLISH
75UNAPPROVED
Division of Northeast Imports (DNEI)

Frequently Asked Questions

What is Janssen Pharmaceutical's FDA import refusal history?

Janssen Pharmaceutical (FEI: 3007501739) has 4 FDA import refusal record(s) in our database, spanning from 3/7/2013 to 4/1/2013.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Janssen Pharmaceutical's FEI number is 3007501739.

What types of violations has Janssen Pharmaceutical received?

Janssen Pharmaceutical has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Janssen Pharmaceutical come from?

All FDA import refusal data for Janssen Pharmaceutical is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.